Suppr超能文献

利尿剂引起的低钠血症和骨质疏松性骨折在急诊科住院患者中的发生情况。

Diuretic-induced hyponatremia and osteoporotic fractures in patients admitted to the emergency department.

机构信息

Department of Emergency Medicine, Inselspital, University Hospital Bern, Switzerland.

出版信息

Maturitas. 2013 May;75(1):81-6. doi: 10.1016/j.maturitas.2013.02.007. Epub 2013 Mar 13.

Abstract

OBJECTIVE

Hyponatremia is a complication of diuretic treatment and has been recently identified as a novel factor associated with osteoporosis and fractures. The impact of diuretic-associated electrolyte disorders on osteoporotic fractures (OF) has rarely been studied systematically.

DESIGN AND SETTING

We conducted a study in patients presenting to the emergency department at the University Hospital Bern. In this retrospective case series analysis of prospectively gathered data, over a 2-year period we identified 10,823 adult (≥50 years) outpatients with a measured baseline serum sodium, at admission to the hospital. OF patients were compared to a control group without fractures using standard statistical methods.

RESULTS

Four hundred and eighty (5%) patients had 547 OF. The OF group had a higher mean age (73 vs. 68 years, p<0.0001), smaller proportion of men (37% vs. 58%, p<0.0001), higher hospitalisation rate (83% vs. 62%, p<0.0001) and longer hospital stay (8 vs. 6 days, p<0.0001). Any diuretic agent (p<0.0001), loop diurietics (p=0.02), spironolactone (p=0.02) and amiloride (p<0.01) were used significantly more in OF patients, but not thiazides (p=0.68). The prevalence of hyponatremia increased significantly (p<0.0001) with the number of diuretics taken. Advanced age (odds ratio [OR] 1.04, p<0.0001), hyponatremia (OR 1.46, p=0.011) higher serum creatinine (OR 1.53, p=0.0001), furosemide use alone (OR 1.40, p=0.01) and co-treatment with amiloride (OR 2.22, p=0.02) were associated with a higher risk for OF.

CONCLUSIONS

This study highlights the clinical association of hyponatremia during the use of certain diuretics (i.e. furosemide or in combination, i.e. amiloride) with an increased risk of osteoporosis associated fractures. Although evidence-based data is currently lacking a pragmatic approach concerning hyponatremia monitoring and correction appears reasonable in selected groups of patients.

摘要

目的

低钠血症是利尿剂治疗的并发症,最近已被确定为与骨质疏松症和骨折相关的新因素。利尿剂相关电解质紊乱对骨质疏松性骨折(OF)的影响很少被系统研究。

设计和设置

我们在伯尔尼大学医院急诊科的患者中进行了一项研究。在这项前瞻性收集数据的回顾性病例系列分析中,我们在 2 年期间确定了 10823 名年龄在 50 岁以上的成年门诊患者,他们在入院时测量了基础血清钠。OF 患者与无骨折的对照组使用标准统计方法进行比较。

结果

480 名(5%)患者有 547 例 OF。OF 组的平均年龄更高(73 岁 vs. 68 岁,p<0.0001),男性比例更小(37% vs. 58%,p<0.0001),住院率更高(83% vs. 62%,p<0.0001),住院时间更长(8 天 vs. 6 天,p<0.0001)。任何利尿剂(p<0.0001)、袢利尿剂(p=0.02)、螺内酯(p=0.02)和阿米洛利(p<0.01)的使用明显更多,但噻嗪类利尿剂(p=0.68)则不然。低钠血症的患病率随着利尿剂使用数量的增加而显著增加(p<0.0001)。高龄(优势比 [OR] 1.04,p<0.0001)、低钠血症(OR 1.46,p=0.011)、血清肌酐升高(OR 1.53,p=0.0001)、单独使用呋塞米(OR 1.40,p=0.01)和与阿米洛利联合治疗(OR 2.22,p=0.02)与骨质疏松症相关骨折的风险增加相关。

结论

本研究强调了在使用某些利尿剂(即呋塞米或联合使用,即阿米洛利)期间发生低钠血症与骨质疏松症相关骨折风险增加之间的临床关联。尽管目前缺乏基于证据的数据,但在某些选定的患者群体中,监测和纠正低钠血症似乎是合理的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验